A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)

NCT00500149 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
129
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shire